CEO Dave Ricks says Lilly’s weight loss pill, or foragliprone, could get FDA approval in 2026

Eli Lilly & Co., the Fortune 500 pharma firm that makes the weight-loss injection Zepbound (tirzepetide), has a comparable oral ...
Read more